GO:1904464 regulation of matrix metallopeptidase secretion: Secretory Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904464 describes any process that modulates the frequency, rate or extent of matrix metallopeptidase (MMP) secretion, a key step in extracellular matrix remodeling [1,3].
• MMP secretion is tightly regulated at multiple levels, including post-translational modifications, vesicle trafficking, and invadopodia dynamics [1,3,6].
• Dysregulated MMP secretion contributes to cancer invasion, metastasis, neuroinflammation, and developmental defects [1,2,3,4,8].
• Key proteins involved include Talin2, DCLK1, MMP9, MMP12, MMP28, and ADAM/ADAMTS family members [1,2,3,4,5].
• CRISPR-based models (knockout, knock-in, overexpression) are essential to dissect the causal roles of genes regulating MMP secretion [1,3,8].
• EDITGENE provides custom cell models and screening services to study GO:1904464 in relevant disease contexts.
Description
Matrix metallopeptidases (MMPs) are a family of zinc-dependent endopeptidases that degrade extracellular matrix components and are critical for tissue remodeling, development, and disease progression [5,6]. The process of MMP secretion is not passive; it is actively regulated to ensure that these enzymes reach the extracellular space only when needed. GO:1904464, regulation of matrix metallopeptidase secretion, encompasses all molecular events that control the frequency, rate, or extent of MMP release from cells [1,3]. This regulation is essential for normal physiology, including sperm fate and synaptic stripping, and its dysregulation is implicated in cancer, inflammation, and neurodegeneration [2,4,5,8]. Understanding how MMP secretion is controlled offers opportunities for therapeutic intervention and biomarker discovery [3,8].
regulation of matrix metallopeptidase secretion At A Glance
| GO ID | GO:1904464 |
|---|---|
| GO term | regulation of matrix metallopeptidase secretion |
| Ontology | biological_process |
| Synonym | regulation of MMP secretion; regulation of matrix metalloproteinase secretion |
| Major function | Modulates the release of MMPs to the extracellular space, influencing ECM remodeling and cell migration [1,3] |
| Key regulators | Talin2, DCLK1, IL-1alpha, and epigenetic modifiers [1,3,7,8] |
| Disease relevance | Cancer invasion, metastasis, neuroinflammation, and developmental disorders [2,3,4,8] |
| Research methods | Live-cell imaging, invadopodia assays, CRISPR screens, proteomics [1,3,8] |
What Is GO:1904464?
GO:1904464 is defined as any process that modulates the frequency, rate or extent of matrix metallopeptidase secretion. In other words, it includes the signaling, trafficking, and post-translational mechanisms that determine how much active MMP is released from a cell, rather than the catalytic activity of the MMP itself [1,3,6].
Why Is regulation of matrix metallopeptidase secretion Important in Cell Biology?
Regulation of MMP secretion is a central node in tissue remodeling and disease. Because MMPs can degrade basement membrane and extracellular matrix, their inappropriate secretion drives tumor cell invasion and metastasis [3,8]. Conversely, insufficient or mislocalized MMP secretion contributes to defective synaptic stripping and abnormal sperm fate [2,5]. Understanding GO:1904464 therefore has broad implications for cancer biology, neuroscience, and reproductive biology, and it provides a target for therapeutic modulation [1,4,7].
• Controls extracellular matrix turnover and tissue homeostasis [5,6].
• Critical for cancer cell invasion and metastasis through invadopodia [1,3].
• Involved in neuroinflammation and synaptic stripping after injury.
• Affects sperm maturation and fate decisions.
• Modulated by inflammatory cytokines such as IL-1alpha.
• Regulated by epigenetic mechanisms that drive metastasis.
• Potential target for anti-metastatic therapies [3,8].
• Provides biomarkers for head and neck, pancreatic, and other cancers [3,4].
• Essential for normal development and wound healing [5,6].
What Happens During regulation of matrix metallopeptidase secretion?
MMP biosynthesis and post-translational modification
In simple terms: Before an MMP can be secreted, it must be made and modified inside the cell.
MMPs are synthesized as preproenzymes and undergo post-translational modifications such as glycosylation and phosphorylation that influence their stability, trafficking, and activity. These modifications determine whether the MMP is directed to secretory vesicles or degraded.
Vesicular trafficking and invadopodia formation
In simple terms: MMPs are packaged into vesicles and transported to the cell surface for release.
Talin2 mediates the secretion and trafficking of MMP9 during invadopodium formation, a specialized actin-rich structure that degrades ECM. DCLK1 regulates invadopodia dynamics and MMP trafficking, promoting invasive progression in head and neck squamous cell carcinoma.
Regulation by cytokines and signaling pathways
In simple terms: External signals can turn MMP secretion up or down.
Interleukin-1alpha regulates MMP9 secretion and activation in epithelial cells of odontogenic jaw cysts. MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling-dependent cytokine secretion, indirectly influencing the tumor microenvironment.
Epigenetic control of MMP secretion
In simple terms: Chemical tags on DNA or histones can change how much MMP is secreted.
Epigenetic drivers, including DNA methylation and histone modifications, regulate metalloproteinase expression and secretion, contributing to metastasis. These mechanisms can silence or activate MMP genes in a cell-type-specific manner.
Physiological roles: synaptic stripping and sperm fate
In simple terms: MMP secretion is important for normal processes like nerve repair and sperm development.
Up-regulation of MMP12 in motor neurons undergoing synaptic stripping suggests a role in nervous system remodeling. MMPs, ADAMs, and ADAMTSs are associated with mammalian sperm fate, highlighting their importance in reproduction.
Key Genes Involved in GO:1904464 regulation of matrix metallopeptidase secretion
The following genes and proteins are experimentally implicated in the regulation of MMP secretion, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Talin2 | Mediates secretion and trafficking of MMP9 during invadopodium formation | Invadopodia biology, cancer invasion |
| DCLK1 | Regulates invadopodia dynamics and MMP trafficking | Head and neck squamous cell carcinoma |
| MMP9 | Secreted gelatinase involved in ECM degradation [1,7] | Cancer, inflammation, odontogenic cysts [1,7] |
| MMP12 | Macrophage metalloelastase up-regulated in motor neurons | Synaptic stripping, neuroinflammation |
| MMP28 | Recruits M2 macrophages via cytokine secretion | Pancreatic cancer progression |
| IL-1alpha | Cytokine regulating MMP9 secretion and activation | Odontogenic jaw cysts |
| ADAMs | Membrane-anchored metalloproteinases associated with sperm fate | Reproductive biology |
| ADAMTSs | Secreted metalloproteinases associated with sperm fate | Reproductive biology |
| Epigenetic modifiers | Regulate metalloproteinase expression and secretion | Metastasis, epigenetic therapy |
| MAPK/JNK | Signaling pathway mediating cytokine secretion | Tumor microenvironment |
| MMP2 | Gelatinase often co-secreted with MMP9 | Cancer invasion |
| MMP14 | Membrane-type MMP involved in invadopodia | Cancer, ECM remodeling |
| TIMP1 | Endogenous inhibitor of MMPs, may affect secretion | Cancer, fibrosis |
| TIMP2 | Endogenous inhibitor of MMPs | Cancer, fibrosis |
| CD44 | Cell surface receptor linked to MMP9 secretion | Cancer stemness |
| Cortactin | Actin-binding protein in invadopodia | Invadopodia formation |
| N-WASP | Regulates actin polymerization in invadopodia | Invadopodia formation |
| Rab GTPases | Control vesicle trafficking of MMPs | Secretion pathways |
How Is regulation of matrix metallopeptidase secretion Regulated?
Regulation of MMP secretion occurs at transcriptional, post-transcriptional, and post-translational levels. Epigenetic modifications such as DNA methylation and histone acetylation control MMP gene expression. Cytokines like IL-1alpha stimulate MMP9 secretion through signaling cascades. Post-translational modifications, including phosphorylation and glycosylation, affect MMP trafficking and activity. Additionally, MAPK/JNK signaling modulates cytokine secretion that indirectly influences MMP release.
regulation of matrix metallopeptidase secretion and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Talin2 | Cancer invasion and metastasis | Knockout in cancer cell lines, invadopodia assays |
| DCLK1 | Head and neck squamous cell carcinoma | Knockout or overexpression in HNSCC cells |
| MMP28 | Pancreatic cancer progression | Knockout in pancreatic cancer cells, macrophage co-culture |
| MMP12 | Neuroinflammation, synaptic stripping | Knockout in motor neuron models |
| IL-1alpha | Odontogenic jaw cysts | Knockout in epithelial cells, cytokine stimulation |
Cancer invasion and metastasis
Dysregulated MMP secretion is a hallmark of cancer invasion. Talin2-mediated MMP9 secretion during invadopodium formation promotes ECM degradation and metastasis. DCLK1 regulates invadopodia dynamics and MMP trafficking in head and neck squamous cell carcinoma. MMP28 recruits M2 macrophages via MAPK/JNK signaling to promote pancreatic cancer progression. Epigenetic drivers of metalloproteinases further contribute to metastasis.
Neuroinflammation and synaptic stripping
Up-regulation of MMP12 in motor neurons undergoing synaptic stripping suggests a role for MMP secretion in nervous system remodeling after injury. This process may contribute to neuroinflammatory conditions.
Reproductive biology and sperm fate
MMPs, ADAMs, and ADAMTSs are associated with mammalian sperm fate, indicating that regulated secretion of these enzymes is important for fertility.
Odontogenic jaw cysts
IL-1alpha-dependent regulation of MMP9 secretion and activation in epithelial cells of odontogenic jaw cysts highlights the role of inflammatory cytokines in MMP secretion in benign lesions.
From regulation of matrix metallopeptidase secretion-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Talin2 regulate MMP9 secretion? | Talin2 knockout cancer cells with MMP9 secretion assays |
| What is the role of DCLK1 in invadopodia? | DCLK1 knockout or overexpression in HNSCC cells |
| How does MMP28 affect macrophage recruitment? | MMP28 knockout pancreatic cancer cells co-cultured with macrophages |
| Is IL-1alpha required for MMP9 secretion? | IL-1alpha knockout epithelial cells treated with cytokines |
| Do epigenetic modifiers control MMP secretion? | CRISPR knockout of epigenetic enzymes followed by secretome analysis |
| What is the role of MMP12 in synaptic stripping? | MMP12 knockout motor neurons in injury models |
How to Study the regulation of matrix metallopeptidase secretion Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Vesicle trafficking and secretion dynamics | Invadopodia formation |
| Secretome proteomics | Secreted MMP levels | Identification of MMPs in conditioned media |
| CRISPR screens | Genes regulating MMP secretion | Discovery of novel regulators |
| Invadopodia degradation assay | ECM degradation capacity | Functional assessment of MMP secretion |
| Western blot | MMP protein levels in cells and media | Validation of secretion changes |
| ELISA | Quantification of specific MMPs | Cytokine-induced secretion |
| Zymography | Enzymatic activity of secreted MMPs | Activity assessment |
| RNA-seq | Transcriptional changes in MMP genes | Epigenetic regulation studies |
Live-cell imaging of MMP secretion
Fluorescently tagged MMPs can be tracked in live cells to visualize vesicle trafficking and invadopodia formation [1,3].
Secretome proteomics
Mass spectrometry-based proteomics of conditioned media can identify and quantify secreted MMPs under different conditions [6,8].
CRISPR screens for regulators of MMP secretion
Genome-wide CRISPR knockout or activation screens coupled with MMP activity reporters can identify novel regulators of MMP secretion [3,8].
Invadopodia assays
Matrix degradation assays and immunofluorescence for invadopodia markers measure the functional output of MMP secretion [1,3].
How CRISPR Can Be Used to Study GO:1904464 regulation of matrix metallopeptidase secretion
Knockout
CRISPR knockout of candidate genes such as Talin2, DCLK1, or MMP28 can determine their necessity for MMP secretion [1,3,4]. Knockout cell lines are generated by indel formation in early exons, followed by secretion assays.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to abrogate post-translational modification sites, allowing precise dissection of regulatory mechanisms.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous MMP loci enables real-time tracking of secretion without overexpression artifacts.
Overexpression
Overexpression of wild-type or mutant MMPs or their regulators can test sufficiency and gain-of-function effects on secretion and invasion [3,8].
How EDITGENE Supports regulation of matrix metallopeptidase secretion Research
Researchers studying regulation of matrix metallopeptidase secretion-related genes often need to determine whether a candidate gene is causally involved in MMP release, and to dissect the precise molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for regulation of matrix metallopeptidase secretion research.
Frequently Asked Questions About regulation of matrix metallopeptidase secretion
What is GO:1904464?
GO:1904464 is a Gene Ontology term for any process that modulates the frequency, rate or extent of matrix metallopeptidase secretion [1,3].
What genes are involved in regulation of matrix metallopeptidase secretion?
Key genes include Talin2, DCLK1, MMP9, MMP12, MMP28, IL-1alpha, and epigenetic modifiers [1,2,3,4,7,8].
How is MMP secretion regulated?
MMP secretion is regulated at transcriptional, post-transcriptional, and post-translational levels, including epigenetic modifications, cytokine signaling, and vesicle trafficking [1,3,6,7,8].
Why is regulation of MMP secretion important in cancer?
Dysregulated MMP secretion promotes ECM degradation, tumor invasion, and metastasis [1,3,4,8].
What diseases are associated with abnormal MMP secretion?
Cancer, neuroinflammation, odontogenic cysts, and reproductive disorders [1,2,4,5,7].
What methods are used to study MMP secretion?
Live-cell imaging, secretome proteomics, CRISPR screens, invadopodia assays, and zymography [1,3,6,7].
How can CRISPR help study GO:1904464?
CRISPR knockout, knock-in, and overexpression models allow causal testing of genes regulating MMP secretion [1,3,8].
What is the role of Talin2 in MMP secretion?
Talin2 mediates secretion and trafficking of MMP9 during invadopodium formation.
How does DCLK1 affect MMP trafficking?
DCLK1 regulates invadopodia dynamics and MMP trafficking in head and neck squamous cell carcinoma.
What is the link between MMP28 and macrophages?
MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling-dependent cytokine secretion.
Conclusion
GO:1904464, regulation of matrix metallopeptidase secretion, is a critical biological process that controls the release of MMPs to the extracellular space. Its dysregulation contributes to cancer, neuroinflammation, and reproductive disorders. Continued research using CRISPR-based models and advanced proteomics will uncover new therapeutic targets and biomarkers.
References
- 1. Baster Z et al.. 2020. Talin2 mediates secretion and trafficking of matrix metallopeptidase 9 during invadopodium formation.. Biochim Biophys Acta Mol Cell Res 1867(7):118693 PMID: 32198023
- 2. Sajjan S et al.. 2014. Up-regulation of matrix metallopeptidase 12 in motor neurons undergoing synaptic stripping.. Neuroscience 274:331-40 PMID: 24907602
- 3. Arnold L et al.. 2025. DCLK1-mediated regulation of invadopodia dynamics and matrix metalloproteinase trafficking drives invasive progression in head and neck squamous cell carcinoma.. Mol Cancer 24(1):50 PMID: 39994636
- 4. Dong S et al.. 2025. MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling pathway-dependent cytokine secretion to promote the malignant progression of pancreatic cancer.. J Exp Clin Cancer Res 44(1):60 PMID: 39972459
- 5. Li Y et al.. 2023. MMPs, ADAMs and ADAMTSs are associated with mammalian sperm fate.. Theriogenology 200:147-154 PMID: 36842259
- 6. Madzharova E et al.. 2019. Post-Translational Modification-Dependent Activity of Matrix Metalloproteinases.. Int J Mol Sci 20(12) PMID: 31238509
- 7. Kubota Y et al.. 2000. Interleukin-1alpha-dependent regulation of matrix metalloproteinase-9(MMP-9) secretion and activation in the epithelial cells of odontogenic jaw cysts.. J Dent Res 79(6):1423-30 PMID: 10890723
- 8. Seehawer M et al.. 2025. Epigenetic drivers of metalloproteinases and metastasis.. Trends Cell Biol 35(12):1054-1067 PMID: 40089451
